Financial results for Q2 ended June 30, 2024
GlaxoSmithKline (Pakistan) Limited (GLAXO) · View GLAXO share price and financials
Published
Announcement summary
This page records a Pakistan Stock Exchange corporate announcement from GlaxoSmithKline (Pakistan) Limited. Review the original filing for the complete terms and regulatory disclosure.
- Unconsolidated Sales
- 13254797
- Unconsolidated Pat
- 1088869
- Unconsolidated Quarter Eps
- 3.42
- Unconsolidated Cumulative Eps
- 5.19